FOXA1-dependent responses of the HER2+ SKBR-3 cell line to lapatinib
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP288463
下载链接
链接失效反馈官方服务：
资源简介：
SKBR-3 HER2+ breast cancer cells were treated with 25 nM Dharmacon siGENOME non-targeting (NT) siRNA control pool or siRNA pool targeting FOXA1 for 48h, then treated with either DMSO or 300nM lapatinib for 24h. Overall design: 12 experimental samples
创建时间：
2023-05-11
